Terms: = Uterine cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
73 results:
1. An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical cancer.
Lukovic J; Pintilie M; Han K; Fyles AW; Bruce JP; Quevedo R; Pugh TJ; Fjeldbo CS; Lyng H; Milosevic MF
Clin Cancer Res; 2024 Mar; 30(6):1200-1207. PubMed ID: 38180733
[TBL] [Abstract] [Full Text] [Related]
2. ROLE OF STROMAL MICROENVIRONMENT IN THE FORMATION OF INVASIVE, ANGIOGENIC, AND METASTATIC POTENTIAL OF ENDOMETRIOID CARCINOMA OF ENDOMETRIUM.
Iurchenko NP; Nesina IP; Glushchenko NМ; Buchynska LG
Exp Oncol; 2023 Jun; 45(1):51-61. PubMed ID: 37417282
[TBL] [Abstract] [Full Text] [Related]
3. RNF113A targeted by miR-197 promotes proliferation and inhibits autophagy via cxcr4/CXCL12/AKT/ERK/Beclin1 axis in cervical cancer.
Zhang Q; Song J; Cao L; Sun M; Xu T; Yang S; Li S; Wang H; Fu X
Exp Cell Res; 2023 Jul; 428(1):113632. PubMed ID: 37164050
[TBL] [Abstract] [Full Text] [Related]
4. Effects of the Ethanol and Ethyl Acetate Extracts of Terminalia chebula Retz. on Proliferation, Migration, and HIF-1α and CXCR-4 Expression in MCF-7 Cells: an In Vitro Study.
Mehrabani M; Jafarinejad-Farsangi S; Raeiszadeh M; Tarzi ME; Sheikholeslami M; Nematollahi MH; Khoshfekr V; Juybari KB; Mehrabani M
Appl Biochem Biotechnol; 2023 May; 195(5):3327-3344. PubMed ID: 36585552
[TBL] [Abstract] [Full Text] [Related]
5. Differences in chemotaxis of human mesenchymal stem cells and cervical cancer cells.
Song Y; Li R; Ye M; Pan C; Zheng L; Wang ZW; Zhu X
Apoptosis; 2022 Dec; 27(11-12):840-851. PubMed ID: 35849265
[TBL] [Abstract] [Full Text] [Related]
6. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial cancer.
Dobroch J; Bojczuk K; Kołakowski A; Baczewska M; Knapp P
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408440
[TBL] [Abstract] [Full Text] [Related]
7. CXCL12/cxcr4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551
[TBL] [Abstract] [Full Text] [Related]
8. Combination of IDO1
Jayakumar H; Seetharaman A; Sunder Singh S; Dhandapani H; Subramani J; Ganeshrajah S; Thangarajan R; Ramanathan P
J Reprod Immunol; 2022 Feb; 149():103454. PubMed ID: 34856521
[TBL] [Abstract] [Full Text] [Related]
9. Expression of chemokine receptor cxcr4 in tumor cells and content of CXCL12
Buchynska LG; Movchan OM; Iurchenko NP
Exp Oncol; 2021 Jun; 43(2):135-141. PubMed ID: 34190517
[TBL] [Abstract] [Full Text] [Related]
10. The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
Xu L; Li C; Hua F; Liu X
Med Oncol; 2021 Apr; 38(5):58. PubMed ID: 33847822
[TBL] [Abstract] [Full Text] [Related]
11. The Oral cxcr4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in Cervical cancer Treated With Radiation Therapy and Concurrent Chemotherapy.
Chaudary N; Hill RP; Stulik L; Milosevic M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1317-1324. PubMed ID: 33771702
[TBL] [Abstract] [Full Text] [Related]
12. [Expression and significance of chemokine CXCL12 and receptor cxcr4 in adenomyosis].
Wang S; Duan H; Li BH; Wang YY; Huang JH; Guo ZC
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):754-759. PubMed ID: 33228346
[No Abstract] [Full Text] [Related]
13. CXCL12 Attracts Bone Marrow-Derived Cells to uterine Leiomyomas.
Moridi I; Mamillapalli R; Kodaman PH; Habata S; Dang T; Taylor HS
Reprod Sci; 2020 Sep; 27(9):1724-1730. PubMed ID: 32020550
[TBL] [Abstract] [Full Text] [Related]
14. Targeting CXCL12/cxcr4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
Lecavalier-Barsoum M; Chaudary N; Han K; Pintilie M; Hill RP; Milosevic M
Br J Cancer; 2019 Jul; 121(3):249-256. PubMed ID: 31239542
[TBL] [Abstract] [Full Text] [Related]
15. Long-Term Outcome of whim Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
[TBL] [Abstract] [Full Text] [Related]
16. CXCL12 modulates the radiosensitivity of cervical cancer by regulating CD44.
Fu Z; Zhang P; Luo H; Huang H; Wang F
Mol Med Rep; 2018 Dec; 18(6):5101-5108. PubMed ID: 30320394
[TBL] [Abstract] [Full Text] [Related]
17. The CXL12/cxcr4/CXCR7 axis in female reproductive tract disease: Review.
Krikun G
Am J Reprod Immunol; 2018 Nov; 80(5):e13028. PubMed ID: 30106199
[TBL] [Abstract] [Full Text] [Related]
18. A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer.
Zhan Y; Zhang H; Dai B; Zhang Y; Zhang J; He L
Oncol Rep; 2018 Aug; 40(2):1064-1072. PubMed ID: 29901176
[TBL] [Abstract] [Full Text] [Related]
19. Nitric oxide signaling regulates tumor-induced intussusceptive-like angiogenesis.
Vimalraj S; Bhuvaneswari S; Lakshmikirupa S; Jyothsna G; Chatterjee S
Microvasc Res; 2018 Sep; 119():47-59. PubMed ID: 29649432
[TBL] [Abstract] [Full Text] [Related]
20. Targeting the CXCL12/cxcr4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
[TBL] [Abstract] [Full Text] [Related]
[Next]
